PL367937A1 - Sposób otrzymywania amorficznej cylastatyny sodowej - Google Patents

Sposób otrzymywania amorficznej cylastatyny sodowej

Info

Publication number
PL367937A1
PL367937A1 PL02367937A PL36793702A PL367937A1 PL 367937 A1 PL367937 A1 PL 367937A1 PL 02367937 A PL02367937 A PL 02367937A PL 36793702 A PL36793702 A PL 36793702A PL 367937 A1 PL367937 A1 PL 367937A1
Authority
PL
Poland
Prior art keywords
preparation
cilastatin sodium
amorphous
amorphous cilastatin
sodium
Prior art date
Application number
PL02367937A
Other languages
English (en)
Inventor
Yatendra Kumar
Om Dutt Tyagi
Amit Rohtagi
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of PL367937A1 publication Critical patent/PL367937A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/02Monohydroxylic acyclic alcohols
    • C07C31/04Methanol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
PL02367937A 2001-05-18 2002-05-17 Sposób otrzymywania amorficznej cylastatyny sodowej PL367937A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN593DE2001 2001-05-18
PCT/IB2002/001696 WO2002094742A1 (en) 2001-05-18 2002-05-17 Process for the preparation of amorphous cilastatin sodium

Publications (1)

Publication Number Publication Date
PL367937A1 true PL367937A1 (pl) 2005-03-07

Family

ID=11097060

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367937A PL367937A1 (pl) 2001-05-18 2002-05-17 Sposób otrzymywania amorficznej cylastatyny sodowej

Country Status (24)

Country Link
US (1) US20040152780A1 (pl)
EP (1) EP1395530A4 (pl)
JP (1) JP2004526805A (pl)
KR (1) KR20040044409A (pl)
CN (1) CN1522235A (pl)
AP (2) AP1511A (pl)
AR (1) AR036017A1 (pl)
BG (1) BG108447A (pl)
BR (1) BR0209843A (pl)
CA (1) CA2447788A1 (pl)
CZ (1) CZ20033352A3 (pl)
EA (1) EA005947B1 (pl)
EE (1) EE200300567A (pl)
HR (1) HRP20031052A2 (pl)
HU (1) HUP0400825A2 (pl)
IL (1) IL158945A0 (pl)
MX (1) MXPA03010547A (pl)
NO (1) NO20035138D0 (pl)
NZ (1) NZ529625A (pl)
OA (1) OA12607A (pl)
PL (1) PL367937A1 (pl)
SK (1) SK15082003A3 (pl)
WO (1) WO2002094742A1 (pl)
ZA (1) ZA200309287B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402312B1 (en) 2005-11-09 2013-07-17 Orchid Chemicals&Pharmaceuticals Limited An improved process for the preparation of cilastatin acid
WO2011080648A1 (en) * 2010-01-01 2011-07-07 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of cilastatin sodium
CN102675175B (zh) * 2011-03-08 2014-02-19 深圳市海滨制药有限公司 一种西司他丁的分离纯化方法
US11324804B2 (en) 2016-11-18 2022-05-10 Sepsia Therapeutics, S.L. Combined CD6 and imipenem therapy for treatment of infectious diseases and related inflammatory processes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
EP0441371B1 (en) * 1990-02-08 1995-01-25 Sumitomo Chemical Company, Limited Process for preparing haloketo acid derivatives
US5166417A (en) * 1990-09-04 1992-11-24 Lonza Ltd. Process for resolution of racemates of 2,2-dimethylcyclopropanecarboxylic acid
CA2056840A1 (en) * 1990-12-17 1992-06-18 Thomas Meul Process for the production of dimethylcyclopropanecarboxylic acid
DE59209523D1 (de) * 1991-07-26 1998-11-19 Lonza Ag Gentechnologisches Verfahren zur Herstellung von S-(+)-2,2-Dimethylcyclopropancarboxamid mittels Mikroorganismen
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (pl) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
EA005947B1 (ru) 2005-08-25
MXPA03010547A (es) 2004-05-27
CN1522235A (zh) 2004-08-18
EA200301225A1 (ru) 2004-06-24
AR036017A1 (es) 2004-08-04
EE200300567A (et) 2004-04-15
EP1395530A1 (en) 2004-03-10
US20040152780A1 (en) 2004-08-05
SK15082003A3 (sk) 2004-06-08
NO20035138D0 (no) 2003-11-18
CA2447788A1 (en) 2002-11-28
BG108447A (en) 2005-03-31
AP2003002913A0 (en) 2003-12-31
OA12607A (en) 2006-06-08
CZ20033352A3 (en) 2004-06-16
HUP0400825A2 (hu) 2004-08-30
IL158945A0 (en) 2004-05-12
EP1395530A4 (en) 2006-01-18
BR0209843A (pt) 2004-08-24
HRP20031052A2 (en) 2004-06-30
KR20040044409A (ko) 2004-05-28
AP2003002912A0 (en) 2002-05-17
JP2004526805A (ja) 2004-09-02
ZA200309287B (en) 2004-07-22
NZ529625A (en) 2006-02-24
WO2002094742A1 (en) 2002-11-28
AP1511A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
HUP0402027A3 (en) Process for the preparation of a xantophyll
PL368984A1 (pl) Sposób otrzymywania krystalicznej postaci imipenemu
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
SI1423360T1 (sl) Postopek za izdelavo cilastatina
PL370705A1 (pl) Sposób wytwarzania imipenemu
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
HUP0501093A2 (en) Process for the isolation of crystalline imipenem
IL158945A0 (en) Process for the preparation of amorphous cilastatin sodium
AU8824201A (en) Process for the preparation of dinapsoline
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
PL371583A1 (pl) Sposób wytwarzania 7 alfa-metylosteroidów
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
IL164788A0 (en) Process for the preparation of 3-isochromanone
HUP0202868A3 (en) Process for preparation of dialkylpyridyl boranes
PL373892A1 (pl) Sposób otrzymywania amorficznej postaci torsemidu
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
AU2166302A (en) Process for the preparation of thiophenols
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)